Background: Amyloid fibers are protein aggregates associated with numerous pathologies.
Results: Mcg light chain variable domains form amyloid fibers through monomers.
Conclusion: This light chain variable domain monomer is the fundamental unit required to form amyloid fibers.
Significance: Understanding the molecular mechanism of Mcg light chain amyloid fiber formation has implications for treating systemic amyloidosis.
Keywords: Amyloid, Antibody, Multiple Myeloma, Protein Aggregation, X-ray Crystallography, Bence-Jones Proteins, Light Chain Amyloidosis, Light Chain Variable Domains, Systemic Amyloidosis
Abstract
Systemic light chain amyloidosis is a lethal disease characterized by excess immunoglobulin light chains and light chain fragments composed of variable domains, which aggregate into amyloid fibers. These fibers accumulate and damage organs. Some light chains induce formation of amyloid fibers, whereas others do not, making it unclear what distinguishes amyloid formers from non-formers. One mechanism by which sequence variation may reduce propensity to form amyloid fibers is by shifting the equilibrium toward an amyloid-resistant quaternary structure. Here we identify the monomeric form of the Mcg immunoglobulin light chain variable domain as the quaternary unit required for amyloid fiber assembly. Dimers of Mcg variable domains remain stable and soluble, yet become prone to assemble into amyloid fibers upon disassociation into monomers.
Introduction
Bence-Jones proteins were first reported over a century and a half ago as disease-associated substances and later shown to be immunoglobulin light chains involved in systemic light chain amyloidosis, amyloid formation frequently associated with multiple myeloma (1–5). Light chains (LC)5 are classified by amino acid sequence as either of two types, κ or λ, and consist of two domains, the constant (CL)6 and the variable (VL) connected by a joining (J) segment (6). In this disease, immunoglobulin light chains are overexpressed, increasing the ratio of light to heavy chains. This disturbance of the balance between light and heavy chains results in the formation of LC homo-dimers termed Bence-Jones proteins.
Amyloid fibers are insoluble protein deposits, often associated with disease, which are induced by particular peptide sequences and exhibit common structural and biochemical characteristics. Specifically, all amyloid fibers contain a β-sheet rich spine, which serves as a scaffold for fiber extension and gives rise to a distinctive cross-β x-ray diffraction pattern (7–9). The core of amyloid fibers consists of a pair of β-sheets, whose side chains interdigitate, forming a stable spine termed a steric zipper (10). Formation of a steric zipper requires the presence of a short peptide segment with an amino acid sequence capable of forming a self-complimentary propagating structure upon exposure to solvent (11). In systemic LC amyloidosis, both the full-length LCs (VL-J-CL) and their VLs are found to be constituents of amyloid fibers, yet the ubiquitous presence of VLs indicates that this domain may be essential for their assembly (12–17). The peptide segments within VLs responsible for forming the steric zipper remain unknown. Due to somatic recombination of immunoglobulins, the LC amino acid sequence is different in every patient; however, the disease has a common progression and pathology leading to the secretion of excess monoclonal LCs through the renal tract (18). Despite renal clearance, full-length LCs or LC fragments that contain the variable domain still form amyloid deposits in the tissues of patients, thereby resulting in organ failure (19).
Although excess LCs and VLs form amyloid fibers, most of their known molecular structures are homo-dimers with the two variable domains resembling a light chain and a heavy chain variable domain in a full antibody (20–22). The VL homo-dimer resembles the structure of the region of antibodies termed the antigen-binding fragment (Fab), which is composed of both light chains and heavy chains, each with constant (CH) and variable (VH) immunoglobulin domains. In the Fab, a disulfide bond covalently links the C termini of the LC and heavy chains, and noncovalent dimer interfaces form hydrophobic cavities between the CH and CL and between the VH and VL. Similarly to the Fab, a disulfide bond links full-length LC homo-dimers at the C termini, and the two VLs form a noncovalent dimer. The dimer interfaces of both the VH-VL hetero-dimer of Fab and the pathologic VL-VL homo-dimer are lined with apolar residues enclosing a cavity capable of accommodating hydrophobic molecules (23, 24).
The pathway by which variable domains form amyloid fibers remains uncertain; however, there are several hypotheses. Early models of VL amyloid assembly proposed that continuous semi-crystalline fibers are formed by VL dimers that preserve their native or a native-like conformation with a conserved hydrophobic dimer interface (25). We term these dimers canonical dimers and term this model the canonical dimer model. This model suggests that canonical VL dimers, which resemble the structure of antigen-binding variable domains in a full antibody, stack to form noncovalent filamentous polymers with the width of a single VL dimer. The dimer interface of the two VL domains would need to form a continuous pair of β-sheets to give rise to the observed cross-β x-ray diffraction pattern. Then, several of these filaments pack into stable amyloid fibers through intermolecular interactions between strands G-F-C-C′ of the Greek fold (26). This model proposes that semi-crystalline amyloid fibers contain globular VLs in a conformation similar to that observed in crystals (Protein Data Bank (PDB) 1REI) (27). Because the canonical dimer model assumes the presence of globular VLs with a conserved three-dimensional structure, it also assumes that amyloid formation is reversible.
Although most VLs crystallize as canonical dimers, several VLs, both κ and λ types, display conformations in which the orientation of domains relative to each other is altered. The most pronounced change includes a rotation up to 180° around an axis perpendicular to the plane of the dimer interface, whereas the hydrophobic environment of the cavity between the VLs is conserved (28, 29). These structural alterations suggest the possibility of alternative amyloid formation pathways through which noncanonical dimers, lacking the stability of canonical dimers, assemble amyloid fibers in either the globular or the partially unfolded state. If the globular state is maintained in the fiber, the noncanonical dimers would need to stack as continuous β-sheets, similar to the model for amyloid formation by canonical dimers. Alternatively, the VLs of a noncanonical dimer may partially unfold without disassociation to form steric zippers, whereas the hydrophobic interface between domains is maintained. Based on this model, which we term the noncanonical dimer model, destabilizing mutations would induce partial unfolding to an amyloid-prone tertiary conformation, whereas stabilizing mutations would inhibit amyloidosis (30–32).
In addition to forming canonical and noncanonical dimers, VLs also exist as monomers in solution. Experiments conducted in denaturing conditions indicate that reducing the thermodynamic stability of the monomeric state promotes amyloid fiber formation (33–35). Specifically, the introduction of mutations that induce dimer disassociation or promote monomer unfolding increases the propensity to form amyloid fibers. These findings gave rise yet another model for VL amyloid assembly; partially unfolded monomers polymerize into amyloid fibers, whereas dimers protect against amyloidosis. We term this the monomer model.
Although many VLs have been examined and different models for formation of their amyloid fibers have been proposed, it remains unclear which VL quaternary state promotes amyloid fiber assembly and whether fibers contain unfolded, partially folded, or globular VLs (36). Such ambiguity limits our ability to identify peptide segments that form the amyloid spine. If amyloid fibers contain globular dimers with a preserved dimer interface, amyloidogenic segments can map only to solvent-accessible areas of VLs. However, if unfolded VL monomers compose amyloid fibers, then amyloidogenic segments can map anywhere within the entire VL sequence.
We seek to identify the immunoglobulin VL quaternary state that is the precursor to formation of amyloid fibers and to identify which of the three models best describes the amyloid-forming process (Fig. 1). Because the three-dimensional structure of canonical VL dimers mimics the conformation of physiological Fab antigen-binding domains, which are abundant in human blood as a part of antibodies and are not pathological, the canonical dimers formed by excess VLs and full-length LCs may not form amyloid fibers prior to a structural rearrangement. The existence of various noncanonical VL dimers and monomers suggests a transition between alternative conformations through a monomeric VL: the quaternary state that may be prone to form amyloid. Here, we investigate whether VL monomers alone are able to form fibers and thus clarify which of the models explains the molecular pathway of VL amyloid formation.
FIGURE 1.

Hypothetical pathways for the conversion of immunoglobulin VL dimers to amyloid fibers. The left-hand pathway depicts the canonical dimer observed in several crystal structures, which then stacks into an amyloid fiber. The right-hand pathway depicts one of several noncanonical dimers, also seen in crystal structures. In these dimers, the quaternary structure of the two light chain variable domains differs from the canonical dimer, but each domain retains its tertiary conformation, and the dimer stacks into an amyloid fiber. The central pathway depicts the disassociation of the dimer to monomers, which then partially unfold and form an amyloid fiber. In this study, we assess which of these three models best describes the quaternary state most prone to forming amyloid fibers.
EXPERIMENTAL PROCEDURES
Preparation of Mcg Mutant Proteins
The peptide sequence for the Mcg protein was obtained from the PDB entry 3MCG. The DNA sequence was synthesized by GenScript and cloned into the pET26b+ expression vector. The N termini of the proteins contained a His6 tag followed by a TEV protease cleavage site. Mcg-Y38E-F99A-F101E and Mcg-A45C-F101C were prepared by means of site-directed mutagenesis PCR. Plasmids with the appropriate sequences were cloned into BL21(DE3)Gold (Agilent Technologies) Escherichia coli expression cells.
Terrific Broth (Fisher Scientific) media were inoculated with expression cultures and allowed to reach A600 nm ∼ 1.0. At this density, production of proteins was induced with 1 mm isopropyl-1-thio-β-d-galactopyranoside and performed overnight at 20 °C. Cells were harvested, resuspended in a 50 mm Tris, pH 8, 100 mm NaCl buffer, and sonicated, and an inclusion bodies pellet was separated from the supernatant by centrifugation. VLs were found in inclusion bodies of the pellet. Inclusion bodies were washed by dissolving the pellet in 50 mm Tris, pH 8, 100 mm NaCl buffer, centrifuged, and separated from the wash supernatant. To solubilize VLs from inclusion bodies, we used a solution of 7 m urea, 50 mm Tris, pH 8, 100 mm NaCl, 0.05% Tween 20. VLs were purified by His tag capture on Ni-NTA columns and eluted with 7 m urea, 50 mm Tris, pH 8, 100 mm NaCl, 0.05% Tween 20, 0.5 m imidazole. Following Ni-NTA capture, the proteins were dialyzed against a solution of 50 mm Tris, pH 8, 100 mm NaCl, 10% glycerol, 0.1 m l-arginine, 0.05% Tween 20. TEV protease digestion was performed by the addition of 1% w/w of TEV protease to the total protein mass and the addition of reduced/oxidized glutathione to 3 mm/0.3 mm, respectively. TEV protease digestion was conducted overnight at room temperature and monitored by SDS-PAGE. Urea was added to a final concentration of 7 m, and undigested protein, cleaved His tags, and His-tagged TEV protease were separated from VLs by means of Ni-NTA columns. The flow-through was collected and contained VLs denatured in urea buffer. Proteins were dialyzed against 50 mm Tris, pH 8, 100 mm NaCl, 10% glycerol, 0.1 m l-arginine, 0.05% Tween 20. To assist with proper refolding of the Mcg-A45C-F101C mutant, DTT was added to a final concentration of 5 mm in the dialysis buffer. After refolding, the proteins were concentrated in Centricon devices with a 10-kDa cutoff and washed three times with 25 mm Tris, pH 8, 50 mm NaCl.
Amyloid Fiber Formation Assays
Thioflavin T (ThT) assays were performed by diluting the protein with 50 mm acetic acid/sodium acetate, pH 4, 150 mm NaCl buffer, and 0.05 mm ThT to a final concentration of 0.5 mg/ml. In reducing conditions, the proteins were first treated with 1 mm DTT for 5 min and then diluted to 0.5 mg/ml with 50 mm acetic acid/sodium acetate, pH 4, 150 mm NaCl buffer, 0.05 mm ThT, and 1 mm DTT. Formation of amyloid fibers was performed at 37 °C with constant shaking in black NUNC micro plates with Teflon balls with radii of 0.125 inches as stirrers. Fluorescent measurements of ThT were acquired with a Varioskan spectrophotometer at 444/482 nm excitation/emission wavelengths (37).
Electron Microscopy
Following the completion of ThT assays, samples were collected, diluted with water to 10% v/v, and applied onto electron microscopy copper grids. The grids were stained with 2% uranyl acetate, and images were collected by means of a Tecnai T12 electron microscope at 120 kV with a Gatan CCD camera.
Crystal Structure Determination
Crystallization trials were set up in hanging drop plates with a Mosquito micro-crystallization robot. Crystals were cryo-protected with 25% glycerol, and data were collected with a Rigaku HTC or at the Advanced Photon Source (APS), Argonne, IL, at the 24-ID-C and 24-ID-E beamlines. Data were processed with Denzo and scaled with Scalepack or with the XDS package (61, 62). Phases were resolved by means of molecular replacement with Phaser, using a variable domain fragment from chain A of PDB 3MCG as the initial model. Protein models were refined with Refmac5 (63). Graphics were rendered with PyMOL (60). PDB accession codes and x-ray data collection and refinement statistics are in Table 1.
TABLE 1.
X-ray data collection and refinement statistics
Each structure was derived from a single crystal.
| Mcg PDB 4UNU | Mcg-A45C-F101C (covalent dimer) PDB 4UNV | Mcg-Y38E-F99A-F101E (monomer) PDB 4UNT | |
|---|---|---|---|
| Data collection | |||
| Space group | P1211 | C2221 | C121 |
| Cell dimensions | |||
| a, b, c (Å) | 41.3, 34.1, 63.3 | 37.4, 60.2, 79.4 | 103.1, 90.3, 99.2 |
| α, β, γ (°) | 90.0, 104.9, 90.0 | 90, 90, 90 | 90, 118.8, 90 |
| Resolution (Å) | 40-0.95 (0.97)a | 30-1.6 (1.64) | 65-2.7 (2.77) |
| Rsym or Rmerge | 0.07 (0.7) | 0.06 (0.4) | 0.09 (0.3) |
| I/σI | 21 (1.9) | 39 (4.2) | 13 (4.3) |
| Completeness (%) | 88 (34) | 98 (86) | 98 (99) |
| Redundancy | 12 (3.2) | 7 (3.6) | 4 (3.8) |
| Refinement | |||
| Resolution (Å) | 40-0.95 | 30-1.6 | 64-2.7 |
| No. of reflections | 89,567 | 11,350 | 20,681 |
| Rwork/Rfree | 0.11/0.13 | 0.20/0.26 | 0.25/0.29 |
| No. of atoms | |||
| Protein | 1682 | 794 | 6255 |
| Ligand/ion | 41 | 10 | 65 |
| Water | 373 | 113 | 56 |
| B-factors | |||
| Protein | 9.7 | 24.1 | 31.3 |
| Ligand/ion | 21.9 | 38.8 | 54.1 |
| Water | 28.8 | 35.4 | 18.9 |
| r.m.s.b deviations | |||
| Bond lengths (Å) | 0.026 | 0.018 | 0.010 |
| Bond angles (°) | 2.291 | 1.962 | 1.448 |
| Crystallization conditions | |||
| 2 m NaCl, 2 m (NH4)2SO4 | 0.1 m CH3COONa pH 4.6, 2 m (NH4)2SO4 | 0.5 m LiCl, 1.65 m (NH4)2SO4 | |
a Highest resolution shell is shown in parentheses.
b r.m.s., root mean square.
Native State Mass Spectrometry, Quadrupole Time-of-flight
For native mass spectrometry, protein samples were dialyzed into 50 mm ammonium bicarbonate immediately prior to analysis under native conditions. The sample solution was infused by a syringe pump (20 μl/min) to the electrospray source of a quadrupole time-of-flight mass spectrometer operating in positive ion mode (Agilent Technologies 6550 with dual Agilent Jet Stream source). The instrument was operated in the “extended mass range” mode at 2 GHz for scanning to 10,000 m/z. Quadrupole transmission was set to 1,000 m/z, and various parameters were adjusted to lower the energy delivered to the analyte, including the sheath gas temperature of 125 °C and flow of 3 liters/min with a fragmentor voltage of 200 V. Mass spectra were analyzed with MassHunter Qualitative Analysis software (Agilent Technologies).
Analytical Ultracentrifugation
Sedimentation equilibrium runs were performed on the native Mcg, the covalent Mcg dimer, and the VL monomer at 4 °C in a Beckman Optima XL-A analytical ultracentrifuge using absorption optics at 280 nm. Samples were at concentrations of 0.094, 0.28, and 0.44 mg/ml. Additional concentrations of 0.38 and 1.5 mg/ml were also run for the native Mcg. A 12-mm path length six-sector cell was used for all samples, except for the sample at 1.5 mg/ml, for which a 3-mm path length double sector cell was used. Samples were in 50 mm NaCl, 25 mm Tris, pH 8. Sedimentation equilibrium profiles were measured at speeds of 14,000, 17,000, and 22,000 rpm. The data were initially fitted with a nonlinear least-squares exponential fit for a single ideal species using the Beckman Origin-based software (Version 3.01). The Beckman global analysis software (the “multifit” option of the above mentioned software) was then used to analyze multiple scans, corresponding to different input concentrations and speeds, simultaneously for various models. Partial specific volumes of 0.709 (native Mcg) and 0.707 (VL monomer and covalent Mcg dimer) were used. These were calculated from the amino acid composition and corrected to 4 °C (38, 39).
Chemical Denaturation Analysis
The stability of the proteins with and without 1 mm DTT was assessed by titrating the samples with urea and monitoring tryptophan fluorescence (40). The excitation wavelength was set at 295 nm, and the emission spectra were recorded from 325 to 400 nm. The maximal emission change along the titration occurred at 355 nm. The experiment was performed with a Molecular Devices SpectraMax fluorometer and quartz cuvette with a 1-cm path length. The concentration of protein in all samples was 0.1 mg/ml.
Fluorescence data points indicating cooperative denaturation through logarithmic analysis were fit to the sigmoidal equation (Y = Bottom + (Top − Bottom)/(1 + 10∧((LogEC50 − X) × Hill slope)) (where the ∧ symbol indicates to the mathematical power of) using GraphPad Prism version 6 for Windows (GraphPad Software, La Jolla, CA). The urea concentration corresponding to denaturation of half of the protein (IC50) was used to assess the stability of the proteins.
RESULTS
Design of a Covalently Linked VL Dimer and an Induced VL Monomer
The pathologic Mcg identified by Edmundson and co-workers (21, 41)is a λ LC homo-dimer that was isolated from a patient and served as a model in many previous experiments, making it a particularly informative variant for studying the amyloidogenic behavior of VLs in our research. The crystal structure of Mcg VLs appears as a homo-dimer (PDB 3MCG) with an overall conformation similar to the canonical VH-VL hetero-dimer of Fab (42, 43). The structural integrity of the Fab is mimicked in Mcg because the dimer interface between the VLs, which contains strands G-F-C-C′ of the immunoglobulin Greek key fold, is preserved (26).
To verify whether pure VL monomer or a dimer forms amyloid fibers and to examine in physiological conditions findings previously found in denaturing conditions (33, 44, 45), we generated distinct, soluble, quaternary forms of the model VL domains: the native Mcg dimer consisting of two individual VLs bound by noncovalent interactions, a covalently linked Mcg dimer with disulfide bonds welding the two individual VLs as a dimer, and an induced VL monomer. In near physiological conditions, we examined which of the three states of Mcg can assemble into amyloid fibers.
To produce the covalent Mcg dimer, residues appropriately located for site-directed mutagenesis to cysteine were identified based on the crystal structure of the native Mcg VL dimer (Fig. 2, Table 1). The Mcg crystal structure shows the proximity of residues Ala-45 and Phe-101 at the interface of the identical VLs of the dimer. Therefore, we created a covalent Mcg dimer by mutagenesis of both of these residues to cysteine (Mcg-A45C-F101C). When purified, a nonreducing SDS-PAGE shows a molecular mass of ∼30 kDa as expected for a Mcg dimer. In addition, the crystal structure of Mcg-A45C-F101C clearly shows the presence of the two designed disulfide bonds between the adjacent VLs (Fig. 2). Upon reduction of the disulfide bonds, the SDS-PAGE shows a molecular mass that matches that of the native Mcg, ∼15 kDa.
FIGURE 2.
Crystal structures of the native Mcg (PDB 4UNU), the covalent Mcg dimer (PDB 4UNV), and the induced Mcg VL monomer (PDB 4UNT). A, native Mcg. B, Mcg-A45C-F101C covalent dimer. Two disulfide bonds (shown in yellow) between residues 45 and 101 covalently link adjacent VL domains of the dimer. C, the induced monomer Mcg-Y38E-F99A-F101E with swapped G-strands (indicated by Swap). D, SDS-PAGE of the three samples in oxidizing (−) and reducing (+) conditions, where the reductant is DTT. Markers on both sides of the gel indicate molecular mass in kDa. Notice that in reducing conditions, the molecular mass of the dimer corresponds to the mass of the original Mcg and induced monomer.
To induce a soluble VL monomer, residues at the hydrophobic interface between the two VL domains of the native Mcg were mutated to decrease interdomain van der Waals forces and increase solubility. These residues were identified based on the sequence and structural similarity between the native Mcg and its analogous Fab (Fig. 3) and according to their effect on dimerization constants as noted by Stevens et al. (46). The crystal structure of the most similar full-length antigen-binding fragment (Fab) (PDB 3TNM) was determined by means of amino acid sequence alignment of the native Mcg with proteins deposited in the Protein Data Bank. Comparison of the three-dimensional VL models indicates that not only do the native Mcg and the corresponding Fab overlay closely, but apolar residues at the hydrophobic interface overlay as well. Upon the alignment of crystal structures, Mcg residues Tyr-38, Phe-99, and Phe-101 were identified among several conserved key residues that form the hydrophobic interface of the VL dimer. The residues Tyr-38 and Phe-101 were also noted previously by Stevens et al. (46) to affect disassociation constants of VL dimers in κ variable domains. The triple mutant of Y38E,F99A,F101E removed hydrophobic contacts and introduced two additional charges per monomer, resulting in a soluble VL monomer (Mcg-Y38E-F99A-F101E).
FIGURE 3.
Similarity of the Mcg VL homo-dimer to the VL-VH variable domain hetero-dimer of a physiological Fab (PDB 3TNM). A, the crystal structure of the Fab (PDB 3TNM) reveals a hydrophobic cavity in between the variable domains of its light and heavy chains. The cavity between the VL-VH is lined with side chains of hydrophobic residues. VL is shown in blue, and VH is in green. B, overlay of Fab with Mcg (yellow). Despite differences in residues, the overall structures have identical orientations of domains. C, crystal structure of the Mcg VL-VL dimer. D, sequence alignment of 3TNM and Mcg. Yellow indicates residues that form the hydrophobic interface between variable domains. Notice the similarity of the interface-forming residues of the Mcg VL-VL homo-dimer and the VL-VH hetero-dimer.
Quaternary States of the Proteins in Solution
The distribution of quaternary states of the native Mcg and two mutants in solution was verified by two methods: quadrupole time-of-flight native mass spectrometry and analytical ultracentrifugation. Native state mass spectrometry identified molecular masses for the three proteins (Fig. 4). The VLs of the native Mcg were found to be both dimeric and monomeric, 23.1 and 11.5 kDa respectively, indicating that equilibrium exists between the two quaternary states. The molecular mass of the covalent Mcg dimer was 23.1 kDa, and that of the VL monomer was 11.4 kDa. These results verified the intended effects of the designed mutations on the Mcg quaternary states in solution and confirmed that the native Mcg exists in equilibrium between a VL monomer and dimer.
FIGURE 4.

Deconvoluted protein masses from native state mass spectrometry measurements. A, detected masses for Mcg. The two major peaks show that the protein is found as both a monomer (11557.6 Da) and a dimer (23113.19 Da) in solution. amu, atomic mass units. B, detected mass for the covalent Mcg dimer (Mcg-A45C-F101C, 23150.53 Da). C, detected mass for the induced monomer (Mcg-Y38E-F99A-F101E, 11427.35 Da). Thus, mass spectrometry shows that Mcg is in equilibrium between monomers and dimers.
Analytical ultracentrifugation data for the covalent Mcg dimer and VL monomer gave concentration-independent molecular weights consistent with a dimer and monomer respectively. The native Mcg, however, gave molecular weights that were both speed-dependent (indicating molecular weight heterogeneity) and concentration-dependent (indicating association). A group analysis of 12 files (four concentrations at three speeds) of Mcg found the best fit to be a monomer-dimer equilibrium with a disassociation constant (Kd) of 0.2 ± 0.01 mm (Fig. 5).
FIGURE 5.
Analytical ultracentrifugation data for the native Mcg, covalent dimer, and induced VL monomer. A, fit of three models of the distribution of quaternary states in solution to the native Mcg ultracentrifugation data. The blue curve shows the fit of a pure dimer model, the red curve shows the fit of a pure monomer model, and the green curve shows the fit of a dimer-monomer equilibrium model, which fits best to the data. The fit is shown for the native Mcg at 0.4 mg/ml and a speed of 22,000 rpm. O. D., optical density. B, analytical ultracentrifugation data for the three samples. The top row shows data for the native Mcg, the middle row shows data for the covalent dimer, and the bottom row shows data for the induced VL monomer. The left column shows data for proteins at 0.4 mg/ml, the middle column shows data for 0.3 mg/ml, and the right column shows data for 0.1 mg/ml. O. D. is a measurement of absorption at 280 nm along the radius of the quartz cell from the center of the analytical ultracentrifugation rotor. Measurements were taken only after samples reached equilibrium and the distribution of protein along the cells did not change. Three measurements were made for each analyte at speeds of 22,000, 17,000, and 14,000 rpm. Models of a dimer-monomer equilibrium, pure dimer, and pure monomer were fit to data of the native Mcg, covalent dimer, and induced monomer. The curves of the fit are not clearly visible because of the almost perfect alignment with the experimental data. Residuals show the corresponding error of the fit model to the data.
Stability of the Native Mcg, Covalent Mcg Dimer, and VL Monomer
The stability of the three proteins was examined by titrating with urea and monitoring fluorescence. Logarithmic analysis of the fluorescence data indicates that all the proteins proceed through cooperative unfolding at lower concentrations of urea followed by noncooperative unfolding at higher concentrations (Fig. 6). The urea concentration corresponding to denaturation of half of the protein (IC50) is highest for the covalent Mcg dimer, followed by the native Mcg, and then the induced VL monomer, indicating that the monomer is the least stable. In the presence of DTT, the IC50 of each protein decreases, indicating that the proteins are less stable under reducing conditions. This shows that in addition to reducing the disulfide bond that links the Mcg covalent dimer, the intrachain disulfide bond between residues 22 and 90 of each variable domain is also reduced despite its location in the core of the domain.
FIGURE 6.
Chemical denaturation of the native Mcg, covalent dimer, and induced VL monomer. Cooperative denaturation was detected for the three protein constructs at low concentrations of urea followed by noncooperative denaturation. The concentrations of urea corresponding to denaturation of half of the protein indicate that the covalent Mcg dimer is the most stable quaternary state and the monomer is the least stable. In the table at the bottom of the figure, the ∧ symbol indicates to the mathematical power of.
Effect of Quaternary Structure on Amyloid Fiber Formation
The ability of the native Mcg, covalent Mcg dimer, and VL monomer to form fibers was monitored by an increase in ThT fluorescence and by analysis of transmission electron micrographs for the presence of fibers after the ThT assays. When amyloid fibers formed, catalyzed by an acidic environment and temperature of 37 °C, the ThT assay indicated an increase in fluorescence, and electron micrographs confirmed the presence of fibers (Fig. 7). Although the increase in ThT fluorescence correlates with formation of amyloid fibers, the experiments indicated a variation in intensity and lag times. This variation probably occurs due to differences in nucleation heterogeneity, and therefore, we qualitatively examined ThT fluorescence.
FIGURE 7.
Thioflavin T fiber formation assays and electron micrographs of the native Mcg, covalent Mcg dimer, and induced VL monomer. A and B, averaged fluorescence readings for each protein based on three repeated thioflavin T assays in oxidized and reduced conditions. Error bars are not shown for clarity. C and D, electron micrographs. The only sample that does not form amyloid fibers within 5 days is the covalent Mcg dimer. However, when the covalent cysteine linkages are reduced by DTT, it forms amyloid fibers as readily as the native Mcg and the induced VL monomer. E, raw ThT fluorescence (Fl) data for the three replicated experiments, which are shown averaged in columns A and B.
The native Mcg and VL monomer readily formed fibers in oxidizing and reducing conditions. However, the covalent Mcg dimer did not form fibers in oxidizing conditions. Upon reduction of the disulfides with DTT, the dimer formed amyloid fibers resembling those of the native Mcg and the VL monomer (Fig. 7). Confinement of the covalent Mcg to its canonical dimer conformation abolishes its amyloidogenic property, whereas both the native Mcg, existing in equilibrium between dimers and monomers, and the pure VL monomer are able to form amyloid fibers.
Structures of Designed VL Domains
The structures of the covalent Mcg dimer and of the VL monomer were determined by means of x-ray crystallography, and their conformations remained similar to the native Mcg dimer. The covalent Mcg dimer showed two disulfide bonds between residues 45 and 101 of adjacent VLs, which remained in the same orientation relative to each other as in the native Mcg (Fig. 2). Despite mutations that induced the VL monomer in aqueous solution, it also crystallized in a conformation similar to the native Mcg. However, its crystal structure displayed a phenomenon new to immunoglobulin variable domains; G-strands were swapped among crystallographic dimers, yet the overall immunoglobulin fold remained preserved (Figs. 2 and 8).
FIGURE 8.
The asymmetric unit of domain-swapped VL monomers. Although the Mcg-Y38E-F99A-F101E mutant is monomeric in solution, it resembles the structure of a swapped dimer in the crystal. Note that G-strands of every peptide chain are swapped into a domain in an adjacent dimer.
DISCUSSION
Identification of pathways of assembly from globular proteins into amyloid fibers is essential for understanding amyloid associated diseases. Until now, it has not been clear whether a monomer, dimer, or some other multimeric state of immunoglobulin LCs is the precursor to assembly of amyloid fibers. Three models for the assembly pathway are presented in Fig. 1. Our experiments show that the covalent Mcg dimer is unable to form fibers due to disulfide bonds that bind pairs of VLs and prevent transformation into monomers or a noncanonical dimer. However, upon reduction of the disulfide bonds, the dimer regains the ability to form fibers as readily as the native Mcg and the VL monomer. Therefore, this demonstrates that a canonical dimer of Mcg is protective against amyloid formation, whereas a VL monomer is prone to assemble into amyloid fibers (29, 32, 33). In other words, the monomer model is the most consistent with our data.
Differences in amino acid sequence between various VLs are likely to affect the stability of the dimer and the monomer, which can account for why some VLs are more likely than others to disassociate into monomers and form amyloid fibers (31). In the vast number of possible immunoglobulin variants, each differs from others by only several residues within each of the λ or κ families, and these differences may affect VL dimer-monomer disassociation constants (31, 47). Unstable dimers are more likely to transform between alternative conformations, which protect against amyloid formation to various degrees according to their thermodynamic stability. This transformation is likely to occur by disassociation of the dimer into amyloid-prone monomers, which then can partially unfold and expose a segment that forms the steric zipper spine of the fiber.
Our results are consistent with previous findings that destabilization of VL dimers and unfolding of VL monomers are consecutive yet separate processes (29, 32, 44). Experiments with κ1 O18/O8, AL-09, and SMA VLs show that disassociation of dimers and unfolding of monomers promote amyloid assembly, and in denaturing conditions, mutations that destabilize VL monomers induce formation of amyloid fibers. Similarly, our chemical denaturation experiments suggest that the monomer is the quaternary state that is more prone to unfold, whereas the dimer is protective. Because formation of amyloid fibers depends on a soluble yet unstable monomer, both a stable dimer and a stable monomer would reduce propensity to form amyloid fibers. However, reduction of amyloid formation occurs by two different mechanisms; stable dimers reduce the concentration of soluble monomers, and stable monomers are less likely to unfold and form amyloid fibers. This is similar to pathways by which other amyloidogenic proteins form amyloid fibers; for example, transthyretin disassociates into monomers, and lysozyme must transition through a partially unfolded state to form amyloid fibers (33, 48–51).
Many variants of VLs have been found in patients with systemic light chain amyloidosis, and these variants only differ by a few amino acids (14). Although our experiments were performed with only one variant and a single conformation was imposed on the covalently linked dimer, the fact that a pure, soluble monomer forms amyloid fibers indicates that the monomeric state of the VL is the precursor to amyloid fibers. Due to the similarity in sequence, structure, and biochemical behavior of all light chain variable domains, we infer that our finding for Mcg may well be applied to other light chains and explain the differences in propensity to form amyloid; a stable dimer is less likely to disassociate into monomers, and therefore, less likely to form amyloid.
Although VL dimers must disassociate into monomers to form fibers, structures of full-length LCs indicate that this conformational change can occur regardless of a connection to a constant domain (42). In full-length LCs, VLs are connected to CLs through a joining (J) segment, which provides the domains with the flexibility to acquire conformations independent of each other. Such an architecture of the protein does not impose a particular orientation on VLs relative to connected CLs, as affirmed by the existence of several crystal structures (42, 52, 53). Therefore, a dimer of VLs maintains the ability to disassociate into amyloid-prone VL monomers, while still covalently attached to CLs. This flexibility explains why amyloid fibers of immunoglobulin can consist of full-length LCs, just their VLs, or both.
The crystal structure of our induced VL monomer domain displays an overall conformation similar to the dimer formed by the native Mcg, yet it also shows a phenomenon new to immunoglobulin variable domains where strands are swapped among molecules of the asymmetric unit (Fig. 8). Swapping between segments of protein domains is known to be concentration-dependent and was previously observed in other proteins, such as diphtheria toxin, human prion protein, cystatin C, β2-microglobulin, T7 endonuclease, and helicase (54–58). In closed swapping, protein segments are exchanged between a discrete number of molecules, whereas in runaway swapping, the exchange occurs between an unlimited number, resulting in a continuous polymer (55). In the crystal structure of VL monomers, closed swapping of G-strands occurs between four VL dimers, with both domains of each dimer being swapped. In addition, canonical dimer interfaces link the pairs of swapped dimers in a noncrystallographic octamer with distorted 422 symmetry. Although swapping between domains of VL monomers in solution may play a role in linking molecules in a fiber, the closed swapping in the crystal structure does not resemble a steric zipper spine that would account for the cross-β x-ray diffraction pattern. Although the domain swapping cannot be dismissed as unrelated, its existence in immunoglobulins and relation to their amyloidogenic property is yet unclear.
A practical insight emerging from both past studies and the present study is the possible binding of molecules to the hydrophobic cavity between the variable domains to stabilize the dimer (59). Structures of VL dimers show that a variety of ligands bind to the hydrophobic cavity between the domains (24). Crystallographic models of Mcg indicate that the protein maintains its structure as a canonical dimer while bound to a ligand. The binding of molecules yields an energetically favorable complex, and the equilibrium between different conformations might shift toward a stable dimer rather than an amyloid-prone monomer. Such complexes may therefore inhibit the transition of LC or VL dimers to amyloid fibers, resulting in alleviated symptoms in systemic amyloidosis patients.
Acknowledgments
We thank Mike Collazo for setting up crystallization trials at the UCLA-DOE crystallization facility, M. Capel, K. Rajashankar, N. Sukumar, J. Schuermann, I. Kourinov, and F. Murphy for facilitating x-ray data collection experiments at the Northeastern Collaborative Access Team (NE-CAT) beamlines 24-ID-C and 24-ID-E of the Advanced Photon Source (APS), and Dr. L. Salwinski for valuable comments on the manuscript.
This work was supported, in whole or in part, by National Institutes of Health Grant AG-029430 (to D. S. E.). This work was also supported by National Science Foundation Grant MCB-0958111.
The atomic coordinates and structure factors (codes 4UNT, 4UNU, and 4UNV) have been deposited in the Protein Data Bank (http://wwpdb.org/).
Throughout this study, VL denotes a variable domain of a light chain, VH denotes a variable domain of a heavy chain, CL denotes a constant domain of a light chain, CH denotes a constant domain of a heavy chain, and J denotes a joining segment.
- LC
- light chain(s)
- TEV
- tobacco etch virus
- Ni-NTA
- nickel-nitrilotriacetic acid
- ThT
- thioflavin T.
REFERENCES
- 1. Glenner G. G., Harbaugh J., Ohma J. I., Harada M., Cuatrecasas P. (1970) An amyloid protein: the amino-terminal variable fragment of an immunoglobulin light chain. Biochem. Biophys. Res. Commun. 41, 1287–1289 [DOI] [PubMed] [Google Scholar]
- 2. Glenner G. G. (1973) Immunoglobulin and amyloid fibril proteins. Br. J. Haematol. 24, 533–537 [DOI] [PubMed] [Google Scholar]
- 3. Glenner G. G., Ein D., Eanes E. D., Bladen H. A., Terry W., Page D. L. (1971) Creation of “amyloid” fibrils from Bence Jones proteins in vitro. Science 174, 712–714 [DOI] [PubMed] [Google Scholar]
- 4. Dahlin D. C., Dockerty M. B. (1950) Amyloid and Ymyeloma. Am. J. Pathol. 26, 581–593 [PMC free article] [PubMed] [Google Scholar]
- 5. Jones H. B. (1848) On a new substance occurring in the urine of a patient with mollities ossium. Philos. Trans. R Soc. Lond. 138, 55–62 [Google Scholar]
- 6. Marchalonis J. J., Schluter S. F. (1989) Evolution of variable and constant domains and joining segments of rearranging immunoglobulins. FASEB J. 3, 2469–2479 [DOI] [PubMed] [Google Scholar]
- 7. Sipe J. D., Cohen A. S. (2000) Review: history of the amyloid fibril. J. Struct. Biol. 130, 88–98 [DOI] [PubMed] [Google Scholar]
- 8. Geddes A. J., Parker K. D., Atkins E. D., Beighton E. (1968) “Cross-β” conformation in proteins. J. Mol. Biol. 32, 343–358 [DOI] [PubMed] [Google Scholar]
- 9. Hobbs J. R. (1973) An ABC of amyloid. Proc. R Soc. Med. 66, 705–710 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Eisenberg D., Jucker M. (2012) The amyloid state of proteins in human diseases. Cell 148, 1188–1203 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Nelson R., Sawaya M. R., Balbirnie M., Madsen A. Ø., Riekel C., Grothe R., Eisenberg D. (2005) Structure of the cross-β spine of amyloid-like fibrils. Nature 435, 773–778 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Buxbaum J. (1992) Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. Hematol. Oncol. Clin. North Am. 6, 323–346 [PubMed] [Google Scholar]
- 13. Falk R. H., Comenzo R. L., Skinner M. (1997) The systemic amyloidoses. N. Engl. J. Med. 337, 898–909 [DOI] [PubMed] [Google Scholar]
- 14. Bodi K., Prokaeva T., Spencer B., Eberhard M., Connors L. H., Seldin D. C. (2009) AL-Base: a visual platform analysis tool for the study of amyloidogenic immunoglobulin light chain sequences. Amyloid 16, 1–8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Olsen K. E., Sletten K., Westermark P. (1998) Fragments of the constant region of immunoglobulin light chains are constituents of AL-amyloid proteins. Biochem. Biophys. Res. Commun. 251, 642–647 [DOI] [PubMed] [Google Scholar]
- 16. Lavatelli F., Perlman D. H., Spencer B., Prokaeva T., McComb M. E., Théberge R., Connors L. H., Bellotti V., Seldin D. C., Merlini G., Skinner M., Costello C. E. (2008) Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. Mol. Cell. Proteomics 7, 1570–1583 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Vrana J. A., Gamez J. D., Madden B. J., Theis J. D., Bergen H. R., 3rd, Dogan A. (2009) Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood 114, 4957–4959 [DOI] [PubMed] [Google Scholar]
- 18. Sakano H., Hüppi K., Heinrich G., Tonegawa S. (1979) Sequences at the somatic recombination sites of immunoglobulin light-chain genes. Nature 280, 288–294 [DOI] [PubMed] [Google Scholar]
- 19. Buxbaum J. (1986) Aberrant immunoglobulin synthesis in light chain amyloidosis: free light chain and light chain fragment production by human bone marrow cells in short-term tissue culture. J. Clin. Invest. 78, 798–806 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Colman P. M., Schramm H. J., Guss J. M. (1977) Crystal and molecular structure of the dimer of variable domains of the Bence-Jones protein ROY. J. Mol. Biol. 116, 73–79 [DOI] [PubMed] [Google Scholar]
- 21. Edmundson A. B., Wood M. K., Schiffer M., Hardman K. D., Ainsworth C. F. (1969) A crystallographic investigation of the Mcg myeloma protein, ANL-7635. ANL Rep., 283–285 [PubMed] [Google Scholar]
- 22. Firca J. R., Ely K. R., Kremser P., Westholm F. A., Dorrington K. J., Edmundson A. B. (1978) Interconversion of conformational isomers of light chains in the Mcg immunoglobulins. Biochemistry 17, 148–158 [DOI] [PubMed] [Google Scholar]
- 23. Edmundson A. B., Harris D. L., Fan Z. C., Guddat L. W., Schley B. T., Hanson B. L., Tribbick G., Geysen H. M. (1993) Principles and pitfalls in designing site-directed peptide ligands. Proteins 16, 246–267 [DOI] [PubMed] [Google Scholar]
- 24. Edmundson A. B., Ely K. R., Herron J. N. (1984) A search for site-filling ligands in the Mcg Bence-Jones dimer: crystal binding studies of fluorescent compounds. Mol. Immunol. 21, 561–576 [DOI] [PubMed] [Google Scholar]
- 25. Stevens F. J., Myatt E. A., Chang C. H., Westholm F. A., Eulitz M., Weiss D. T., Murphy C., Solomon A., Schiffer M. (1995) A molecular model for self-assembly of amyloid fibrils: immunoglobulin light chains. Biochemistry 34, 10697–10702 [DOI] [PubMed] [Google Scholar]
- 26. Richardson J. S. (1977) β-Sheet topology and the relatedness of proteins. Nature 268, 495–500 [DOI] [PubMed] [Google Scholar]
- 27. Epp O., Lattman E. E., Schiffer M., Huber R., Palm W. (1975) The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2.0-Å resolution. Biochemistry 14, 4943–4952 [DOI] [PubMed] [Google Scholar]
- 28. Hernández-Santoyo A., del Pozo Yauner L., Fuentes-Silva D., Ortiz E., Rudiño-Piñera E., Sánchez-López R., Horjales E., Becerril B., Rodríguez-Romero A. (2010) A single mutation at the sheet switch region results in conformational changes favoring λ6 light-chain fibrillogenesis. J. Mol. Biol. 396, 280–292 [DOI] [PubMed] [Google Scholar]
- 29. Peterson F. C., Baden E. M., Owen B. A. L., Volkman B. F., Ramirez-Alvarado M. (2010) A single mutation promotes amyloidogenicity through a highly promiscuous dimer interface. Structure 18, 563–570 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Edmundson A. B., Ely K. R., Abola E. E., Schiffer M., Panagiotopoulos N., Deutsch H. F. (1976) Conformational isomerism, rotational allomerism, and divergent evolution in immunoglobulin light chains. Fed. Proc. 35, 2119–2123 [PubMed] [Google Scholar]
- 31. Hurle M. R., Helms L. R., Li L., Chan W., Wetzel R. (1994) A role for destabilizing amino acid replacements in light-chain amyloidosis. Proc. Natl. Acad. Sci. U.S.A. 91, 5446–5450 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Baden E. M., Owen B. A., Peterson F. C., Volkman B. F., Ramirez-Alvarado M., Thompson J. R. (2008) Altered dimer interface decreases stability in an amyloidogenic protein. J. Biol. Chem. 283, 15853–15860 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Qin Z., Hu D., Zhu M., Fink A. L. (2007) Structural characterization of the partially folded intermediates of an immunoglobulin light chain leading to amyloid fibrillation and amorphous aggregation. Biochemistry 46, 3521–3531 [DOI] [PubMed] [Google Scholar]
- 34. Bernier G. M., Putnam F. W. (1963) Monomer-dimer forms of Bence Jones proteins. Nature 200, 223–225 [DOI] [PubMed] [Google Scholar]
- 35. Kishida F., Azuma T., Hamaguchi K. (1975) A type κ Bence Jones protein containing a cysteinyl residue in the variable region. J. Biochem. 77, 481–491 [DOI] [PubMed] [Google Scholar]
- 36. Blancas-Mejía L. M., Ramirez-Alvarado M. (2013) Systemic amyloidoses. Annu. Rev. Biochem. 82, 745–774 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Wall J., Murphy C. L., Solomon A. (1999) In vitro immunoglobulin light chain fibrillogenesis. Methods Enzymol. 309, 204–217 [DOI] [PubMed] [Google Scholar]
- 38. Cohn E. J., Edsall J. T. (1943) Density and apparent specific volume of proteins. in: Proteins, Amino Acids and Peptides as Ions and Dipolar Ions, pp. 370–381, Reinhold Publishing Corp., New York [Google Scholar]
- 39. Laue T. M., Shah B. D., Ridgeway T. M., Pelletier S. L. (1992) Computer-aided interpretation of analytical sedimentation data for proteins. in: Analytical Ultracentrifugation in Biochemistry and Polymer Science, pp. 90–125, The Royal Society of Chemistry, Cambridge, UK [Google Scholar]
- 40. Pace C. N. (1986) Determination and analysis of urea and guanidine hydrochloride denaturation curves. Methods Enzymol. 131, 266–280 [DOI] [PubMed] [Google Scholar]
- 41. Hanson B. L., Bunick G. J., Harp J. M., Edmundson A. B. (2002) Mcg in 2030: new techniques for atomic position determination of immune complexes. J. Mol. Recognit. 15, 297–305 [DOI] [PubMed] [Google Scholar]
- 42. Ely K. R., Herron J. N., Harker M., Edmundson A. B. (1989) Three-dimensional structure of a light chain dimer crystallized in water: conformational flexibility of a molecule in two crystal forms. J. Mol. Biol. 210, 601–615 [DOI] [PubMed] [Google Scholar]
- 43. Bourne P. C., Ramsland P. A., Shan L., Fan Z. C., DeWitt C. R., Shultz B. B., Terzyan S. S., Moomaw C. R., Slaughter C. A., Guddat L. W., Edmundson A. B. (2002) Three-dimensional structure of an immunoglobulin light-chain dimer with amyloidogenic properties. Acta Crystallogr. D Biol. Crystallogr. 58, 815–823 [DOI] [PubMed] [Google Scholar]
- 44. Khurana R., Gillespie J. R., Talapatra A., Minert L. J., Ionescu-Zanetti C., Millett I., Fink A. L. (2001) Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. Biochemistry 40, 3525–3535 [DOI] [PubMed] [Google Scholar]
- 45. Baden E. M., Sikkink L. A., Ramirez-Alvarado M. (2009) Light chain amyloidosis: current findings and future prospects. Curr. Protein Pept. Sci. 10, 500–508 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Stevens F. J., Westholm F. A., Solomon A., Schiffer M. (1980) Self-association of human immunoglobulin κ I light chains: role of the third hypervariable region. Proc. Natl. Acad. Sci. U.S.A. 77, 1144–1148 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Lefranc M. (1999) IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 27, 209–212 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Colon W., Kelly J. W. (1992) Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 31, 8654–8660 [DOI] [PubMed] [Google Scholar]
- 49. Lai Z., Colón W., Kelly J. W. (1996) The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35, 6470–6482 [DOI] [PubMed] [Google Scholar]
- 50. Booth D. R., Sunde M., Bellotti V., Robinson C. V., Hutchinson W. L., Fraser P. E., Hawkins P. N., Dobson C. M., Radford S. E., Blake C. C. F., Pepys M. B. (1997) Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385, 787–793 [DOI] [PubMed] [Google Scholar]
- 51. Fink A. L. (1998) Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold. Des. 3, R9–R23 [DOI] [PubMed] [Google Scholar]
- 52. Terzyan S. S., Bourne C. R., Ramsland P. A., Bourne P. C., Edmundson A. B. (2003) Comparison of the three-dimensional structures of a human Bence-Jones dimer crystallized on Earth and aboard US Space Shuttle Mission STS-95. J. Mol. Recognit. 16, 83–90 [DOI] [PubMed] [Google Scholar]
- 53. Makino D. L., Henschen-Edman A. H., Larson S. B., McPherson A. (2007) Bence Jones KWR protein structures determined by X-ray crystallography. Acta Crystallogr. D Biol. Crystallogr. 63, 780–792 [DOI] [PubMed] [Google Scholar]
- 54. Bennett M. J., Choe S., Eisenberg D. (1994) Domain swapping: entangling alliances between proteins. Proc. Natl. Acad. Sci. U.S.A. 91, 3127–3131 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Bennett M. J., Sawaya M. R., Eisenberg D. (2006) Deposition diseases and 3D domain swapping. Structure 14, 811–824 [DOI] [PubMed] [Google Scholar]
- 56. Liu C., Sawaya M. R., Eisenberg D. (2011) β2-microglobulin forms three-dimensional domain-swapped amyloid fibrils with disulfide linkages. Nat. Struct. Mol. Biol. 18, 49–55 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Guo Z., Eisenberg D. (2006) Runaway domain swapping in amyloid-like fibrils of T7 endonuclease I. Proc. Natl. Acad. Sci. U.S.A. 103, 8042–8047 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Sawaya M. R., Guo S., Tabor S., Richardson C. C., Ellenberger T. (1999) Crystal structure of the helicase domain from the replicative helicase-primase of bacteriophage T7. Cell 99, 167–177 [DOI] [PubMed] [Google Scholar]
- 59. Miroy G. J., Lai Z., Lashuel H. A., Peterson S. A., Strang C., Kelly J. W. (1996) Inhibiting transthyretin amyloid fibril formation via protein stabilization. Proc. Natl. Acad. Sci. U.S.A. 93, 15051–15056 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. DeLano W. L. (2010) The PyMOL Molecular Graphics System, version 1.3r1, Schrödinger, LLC, New York [Google Scholar]
- 61. Otwinowski Z., Minor W. (1997) Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 [DOI] [PubMed] [Google Scholar]
- 62. Kabsch W. (2010) XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125–132 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Murshudov G. N., Vagin A. A., Dodson E. J. (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53, 240–255 [DOI] [PubMed] [Google Scholar]







